Biomarin pharmaceutical inc (BMRN)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
REVENUES:
Total revenues

1,805,372

1,704,048

1,602,819

1,533,428

1,518,510

1,491,212

1,496,303

1,438,745

1,383,348

1,313,646

1,255,432

1,201,180

1,183,863

1,116,854

1,044,699

973,707

923,711

889,895

891,355

859,000

800,652

749,284

666,761

627,086

572,109

548,485

533,550

524,793

512,002

500,723

476,631

461,939

448,551

441,358

435,126

419,451

400,770

376,267

355,460

340,497

0

0

0

Collaborative agreement revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

2,414

3,815

4,198

3,918

3,004

2,460

1,994

1,955

1,822

709

439

468

550

583

606

682

1,155

1,893

0

0

0

OPERATING EXPENSES:
Cost of sales

381,658

359,466

338,586

320,530

322,113

315,264

316,240

296,827

274,113

241,786

229,938

221,196

216,508

209,620

193,516

177,682

164,128

152,008

142,286

137,302

130,449

122,267

101,216

99,350

90,707

88,391

97,653

94,218

95,225

91,830

86,817

84,643

80,332

84,023

82,973

78,531

73,669

70,285

64,786

66,631

0

0

0

Research and development

673,673

715,007

717,585

706,030

695,971

696,328

689,546

682,241

649,698

610,753

617,387

624,115

648,115

661,905

662,781

660,663

651,525

634,806

600,677

567,650

517,451

461,543

416,866

379,244

357,203

354,780

341,831

319,976

312,127

302,218

275,726

268,094

243,191

214,374

198,700

179,489

162,229

147,309

132,103

119,061

0

0

0

Selling, general and administrative

706,061

680,924

657,195

635,649

628,175

604,353

600,462

582,428

572,653

554,336

537,014

525,240

491,312

476,593

447,542

422,828

414,765

402,271

387,758

368,318

334,893

302,156

274,571

261,808

244,375

235,356

218,596

203,092

203,975

198,173

191,615

190,158

179,634

175,423

169,030

162,498

158,760

151,723

138,292

130,471

0

0

0

Intangible asset amortization and contingent consideration

70,020

74,108

63,896

65,413

55,354

48,791

62,384

47,564

50,748

46,471

33,461

39,355

-28,470

-26,953

-74,971

-81,509

-10,150

-17,690

31,411

30,931

17,654

23,709

27,114

34,117

28,427

25,026

26,071

17,875

21,945

18,717

6,651

2,168

3,444

1,428

796

7,808

6,064

6,406

6,252

4,055

0

0

0

Gain on sale of nonfinancial assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of intangible assets

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

1,746,917

1,804,505

1,732,262

1,682,622

1,651,613

1,614,736

1,523,632

1,464,060

1,422,212

1,328,346

1,417,800

1,409,906

1,926,583

1,920,283

1,657,188

1,607,984

1,049,470

1,000,597

1,162,132

1,036,701

932,947

842,175

753,206

775,458

721,651

704,492

684,151

635,161

633,272

610,938

561,377

551,711

506,601

475,248

450,931

421,678

400,722

375,723

341,433

320,218

0

0

0

INCOME (LOSS) FROM OPERATIONS

58,455

-100,457

-129,443

-149,194

-133,103

-123,524

-27,329

-25,315

-38,864

-14,700

-162,368

-208,726

-742,720

-803,429

-612,489

-634,277

-125,759

-110,702

-270,777

-177,701

-132,295

-92,891

-86,445

-148,372

-149,542

-156,007

-150,601

-110,368

-121,270

-110,215

-84,746

-89,772

-58,050

-33,890

-15,805

-2,227

48

544

14,027

20,279

0

0

0

Equity in the loss of BioMarin/Genzyme LLC

-479

-587

-826

-743

-806

-553

-802

-587

-700

-1,291

-1,160

-1,011

-926

-538

-652

-734

-802

-817

-314

-353

-689

-877

-1,540

-1,462

-1,086

-1,149

-964

-1,153

-888

-1,221

-1,577

-1,849

-2,618

-2,426

-2,614

-2,645

-2,842

-2,991

-2,874

-2,781

0

0

0

Interest income

21,694

22,748

23,227

24,225

23,895

22,831

21,963

19,601

17,015

14,853

12,957

10,614

8,988

7,487

6,012

5,723

5,389

4,501

4,694

4,785

5,497

5,937

5,434

4,573

3,488

3,083

2,707

2,911

2,797

2,584

2,451

2,395

2,657

2,934

3,221

3,467

3,704

4,112

4,205

4,123

0

0

0

Interest expense

23,648

23,460

24,276

33,470

38,829

43,664

47,582

46,335

44,150

42,707

40,775

39,871

39,775

39,499

39,100

38,567

38,625

38,244

38,108

37,779

36,998

36,642

35,038

26,446

17,828

10,447

4,784

6,095

7,417

7,639

7,586

7,917

8,193

8,409

9,278

10,118

10,552

10,818

10,952

12,348

0

0

0

Debt conversion expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

-

12,965

0

0

0

-

1,896

0

0

-

0

-

-

-

0

-

-

-

-

Impairment loss on equity investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net gain from sale of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

902

927

2,512

0

0

0

Other income (expense), net

3,476

6,945

2,977

1,606

3,985

2,205

8,954

6,632

4,326

7,970

8,707

10,163

8,203

4,929

147

-1,857

-9,513

-9,462

-9,432

-9,225

-299

-395

570

883

907

982

-1,428

-1,542

-1,595

-1,787

158

-231

74

60

0

0

0

-

-

-

-

-

-

INCOME (LOSS) BEFORE INCOME TAXES

59,498

-94,811

-128,341

-157,576

-144,858

-142,705

-44,796

-46,004

-62,373

-35,875

-182,639

-228,831

-766,230

-831,050

-645,919

-669,549

-169,147

-154,724

-313,426

-219,762

-164,947

-124,868

-118,506

-174,043

-166,606

-176,503

-167,222

-126,667

-138,793

-118,278

-91,300

-99,270

-68,026

-43,627

-39,749

-24,636

-22,884

-21,490

5,333

11,785

0

0

0

Provision for income taxes

-54,508

-70,963

-85,819

-47,398

-55,323

-65,494

80,157

78,856

82,528

81,167

-26,269

-47,563

-202,781

-200,840

-175,046

-145,175

18,202

17,075

-3,213

-7,920

-1,592

9,101

7,656

12,584

8,052

-150

153

-6,955

-8,608

-3,931

-3,230

1,096

5,411

10,209

-459

-220,333

-223,181

-227,309

-219,315

3,159

0

0

0

NET INCOME (LOSS)

114,006

-23,848

-42,522

-110,178

-89,535

-77,211

-124,953

-124,860

-144,901

-117,042

-156,370

-181,268

-563,449

-630,210

-470,873

-524,374

-187,349

-171,799

-310,213

-211,842

-163,355

-133,969

-126,162

-186,627

-174,658

-176,353

-167,375

-119,712

-130,185

-114,347

-88,070

-100,366

-73,437

-53,836

-39,290

195,697

200,297

205,819

224,648

8,626

0

0

0

Earnings Per Share, Basic and Diluted (in dollars per share)

-

-

-

-0.21

-

-

-

-0.09

-

-

-0.07

-0.21

-

-

-

-2.58

-0.51

-

-

-0.51

-0.43

-

-

-

-

-

-

-

-

-

-0.04

-

-0.21

-0.23

-0.16

-0.05

-0.04

-

-

-

0.01

-

-

NET INCOME (LOSS) PER SHARE, BASIC (in dollars per share)

0.45

-

0.31

-

-0.32

-

-0.07

-

-0.25

-

-

-

-0.09

-

-0.22

-

-

-

-0.57

-

-

-0.48

0.05

-0.23

-0.26

-

-0.38

-0.15

-0.31

-

-

-0.27

-

-

-

-

-

-

2.13

0.00

-

0.07

0.01

NET INCOME (LOSS) PER SHARE, DILUTED (in dollars per share)

0.44

-

0.30

-

-0.32

-

-0.07

-

-0.26

-

-

-

-0.09

-

-0.22

-

-

-

-0.60

-

-

-0.47

0.05

-0.23

-0.27

-

-0.38

-0.16

-0.31

-

-

-0.27

-

-

-

-

-

-

1.68

-0.01

-

0.07

0.01

Weighted average common shares outstanding, basic (in shares)

179,898

179,548

179,289

179,048

178,271

177,958

177,481

176,873

175,932

-

-

-

172,710

-

167,714

-

-

-

160,886

-

-

148,277

147,016

146,120

143,983

-

140,796

139,400

127,969

-

-

117,912

-

-

-

-

110,652

107,406

102,110

101,712

101,144

100,331

100,065

Weighted average common shares outstanding, diluted (in shares)

187,163

-

185,924

-

178,271

-

177,481

-

176,150

-

-

-

172,710

-

167,714

-

-

-

161,134

-

-

135,584

159,304

146,351

144,157

-

140,796

139,596

127,969

-

-

117,912

-

-

-

-

110,743

165,864

131,278

101,834

103,720

101,815

101,217

Weighted average common shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

175,103

174,374

-

-

-

162,587

161,548

-

-

160,406

157,612

-

-

-

-

-

-

-

-

-

123,434

-

115,070

-

112,290

111,114

-

-

-

-

-

-

-

COMPREHENSIVE INCOME (LOSS)

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

Net product revenues
Total revenues

1,755,603

1,661,043

1,571,609

1,507,029

1,495,740

1,470,356

1,476,782

1,389,214

1,337,354

1,270,445

1,215,054

1,194,564

1,177,214

1,110,381

1,038,615

968,120

918,567

884,522

885,854

851,503

790,724

738,416

654,950

615,864

560,020

538,360

525,031

517,011

507,602

496,497

471,604

458,185

444,810

437,647

430,060

413,728

394,704

369,701

349,607

334,520

0

0

0

Royalty and other revenues
Total revenues

49,769

43,005

31,210

26,399

22,770

20,856

19,521

49,531

45,994

43,201

40,378

6,616

6,649

6,473

6,933

6,305

5,520

5,373

5,926

7,700

9,967

10,868

9,397

7,407

7,891

6,207

5,515

5,322

2,406

2,271

3,205

3,045

3,302

3,243

4,516

5,140

5,460

5,884

4,698

4,084

0

0

0